AirNexis Therapeutics, Inc., 2026-03-09
An SEC Form D private-offering notice from Palo Alto, CA, a $200,000,000 filer-stated offering target in Biotech. Filed 2026-03-09. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotech developing AN01, a Phase 2 dual PDE3/4 inhibitor for chronic obstructive pulmonary disease (COPD).
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- SmartProperty, Inc., 2026-03-10, $1M, San Diego, CA
- ADVAC Therapeutics Inc, 2026-03-10, $5M, Columus, OH
- MatX Inc., 2026-03-10, $557.9M, Mountain View, CA
- SwitchPoint Bio Holding, Inc., 2026-03-10, $5.3M, Wilmington, DE
- ASCENT HOLDING CO., 2026-03-10, $45.7M, San Diego, CA
- Solstice Oncology, Inc., 2026-03-09, $298.4M, Boston, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.